UB Paderborn / Katalog / Suche / in CDI

Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery

Journal of medicinal chemistry, 2015-10, Vol.58 (20), p.7913-7927

2015

Volltextzugriff (PDF)

Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists

Journal of medicinal chemistry, 2021-06, Vol.64 (12), p.8806-8825

2021

Volltextzugriff (PDF)

The development of diphenyleneiodonium analogs as GPR3 agonists

Bioorganic & medicinal chemistry letters, 2023-10, Vol.94, p.129427-129427, Article 129427

2023

Volltextzugriff (PDF)

Structure-Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074

Molecules (Basel, Switzerland), 2022-09, Vol.27 (17), p.5672

2022

Volltextzugriff (PDF)

Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

European journal of medicinal chemistry, 2022-12, Vol.243, p.114741-114741, Article 114741

2022

Volltextzugriff (PDF)

Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids

Bioorganic & medicinal chemistry, 2021-07, Vol.41, p.116215-116215, Article 116215

2021

Volltextzugriff (PDF)

Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid Receptor

Journal of medicinal chemistry, 2018-05, Vol.61 (10), p.4370-4385

2018

Volltextzugriff (PDF)

Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure–activity

Bioorganic & medicinal chemistry, 2014-06, Vol.22 (11), p.2992-2997

2014

Volltextzugriff (PDF)

Design, Synthesis, and Structure–Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold

ACS chemical neuroscience, 2024-01, Vol.15 (1), p.169-192

2024

Volltextzugriff (PDF)

Substituted Tetrahydroisoquinolines as Selective Antagonists for the Orexin 1 Receptor

Journal of medicinal chemistry, 2013-09, Vol.56 (17), p.6901-6916

2013

Volltextzugriff (PDF)

Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2‑PCCA: Synthesis, Structure–Activity Relationships, and Molecular Modeling Studies

ACS chemical neuroscience, 2016-10, Vol.7 (10), p.1418-1432

2016

Volltextzugriff (PDF)

Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery: Miniperspective

Journal of medicinal chemistry, 2015-10, Vol.58 (20), p.7913-7927

2015

Volltextzugriff (PDF)

Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models

Frontiers in toxicology, 2024-04, Vol.6, p.1346767-1346767

2024

Volltextzugriff (PDF)

The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor

Bioorganic & medicinal chemistry, 2015-09, Vol.23 (17), p.5709-5724

2015

Volltextzugriff (PDF)

Role of the Heme Active Site and Protein Environment in Structure, Spectra, and Function of the Cytochrome P450s

Chemical reviews, 2000-02, Vol.100 (2), p.407-420

2000

Volltextzugriff (PDF)

Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?

American journal of cancer research, 2017-01, Vol.7 (2), p.370-382

2017

Volltextzugriff (PDF)

High-valent intermediates of heme proteins and model compounds

Current Opinion in Chemical Biology, 2001-12, Vol.5 (6), p.724-735

Harris, Danni L

2001

Volltextzugriff (PDF)

Re-sensitizing Multidrug Resistant Bacteria to Antibiotics by Targeting Bacterial Response Regulators: Characterization and Comparison of Interactions between 2-Aminoimidazoles and the Response Regulators BfmR from Acinetobacter baumannii and QseB from Francisella spp

Frontiers in molecular biosciences, 2018-02, Vol.5, p.15-15

2018

Volltextzugriff (PDF)

Optimizing androgen receptor prioritization using high-throughput assay-based activity models

Frontiers in toxicology, 2024-03, Vol.6, p.1347364-1347364

2024

Volltextzugriff (PDF)

Theoretical Investigation of the Proton Assisted Pathway to Formation of Cytochrome P450 Compound I

Journal of the American Chemical Society, 1998-09, Vol.120 (35), p.8941-8948

1998

Volltextzugriff (PDF)

Effect of 1‑Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin‑1 Receptor

ACS chemical neuroscience, 2015-04, Vol.6 (4), p.599-614

2015

Volltextzugriff (PDF)

Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists

ACS chemical neuroscience, 2017-10, Vol.8 (10), p.2290-2308

2017

Volltextzugriff (PDF)

Structure-activity relationship studies on the tetrahydroisoquinoline-based orexin 1 receptor antagonists: The 1-benzyl position

Drug and alcohol dependence, 2015-01, Vol.146, p.e31-e31

2015

Volltextzugriff (PDF)

Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2

Bioorganic & medicinal chemistry letters, 2015-01, Vol.25 (2), p.292-296

2015

Volltextzugriff (PDF)

The effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the Orexin-1 receptor

Drug and alcohol dependence, 2015-11, Vol.156, p.e244-e245

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery

Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists

The development of diphenyleneiodonium analogs as GPR3 agonists

Structure-Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074

Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids

Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid Receptor

Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure–activity

Design, Synthesis, and Structure–Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold

Substituted Tetrahydroisoquinolines as Selective Antagonists for the Orexin 1 Receptor

Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2‑PCCA: Synthesis, Structure–Activity Relationships, and Molecular Modeling Studies

Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery: Miniperspective

Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models

The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor

Role of the Heme Active Site and Protein Environment in Structure, Spectra, and Function of the Cytochrome P450s

Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?

High-valent intermediates of heme proteins and model compounds

Re-sensitizing Multidrug Resistant Bacteria to Antibiotics by Targeting Bacterial Response Regulators: Characterization and Comparison of Interactions between 2-Aminoimidazoles and the Response Regulators BfmR from Acinetobacter baumannii and QseB from Francisella spp

Optimizing androgen receptor prioritization using high-throughput assay-based activity models

Theoretical Investigation of the Proton Assisted Pathway to Formation of Cytochrome P450 Compound I

Effect of 1‑Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin‑1 Receptor

Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists

Structure-activity relationship studies on the tetrahydroisoquinoline-based orexin 1 receptor antagonists: The 1-benzyl position

Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2

The effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the Orexin-1 receptor

Suchergebnisse filtern